The Effect of Paracetamol and Tropisetron on Pain: Experimental Studies and a Review of Published Data

Basic and Clinical Pharmacology and Toxicology

Volumn 112, Issue 2, 2013, Pages 124-131

  Tiippana, Elina ^a   Hamunen, Katri ^a   Kontinen, Vesa ^a   Kalso, Eija ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

GRANISETRON; ONDANSETRON; PARACETAMOL; PLACEBO; TROPISETRON;

ANALGESIA; ARTICLE; CONTACT HEAT PAIN; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ELECTROSTIMULATION; EXPERIMENT; EXPERIMENTAL STUDY; HUMAN; MALE; NOCICEPTION; NORMAL HUMAN; PAIN ASSESSMENT; PAIN THRESHOLD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STIMULUS; VISUAL ANALOG SCALE; WATER IMMERSION;

ACETAMINOPHEN; ADULT; ANALGESICS, NON-NARCOTIC; ANIMALS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DRUG INTERACTIONS; HUMANS; INDOLES; MALE; PAIN; PAIN THRESHOLD; SEROTONIN 5-HT3 RECEPTOR ANTAGONISTS; YOUNG ADULT;

EID: 84872167481     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2012.00935.x     Document Type: Article

References (46)

1. Toms L, McQuay HJ, Derry S, Moore RA. Single dose oral paracetamol (acetaminophen) for postoperative pain in adults. Coch Database Sys Rev 2008; Oct 8(4):CD004602.
2. Bannwarth B, Netter P, Lapicque F, Gillet P, Péré P, Boccard E et al. Plasma and cerebrospinal fluid concentrations of paracetamol after a single intravenous dose of propacetamol. Br J Clin Pharmac 1992;34:79-81.
3. Dinchuk JE, Liu RQ, Trzaskos JM. COX-3: in the wrong frame in mind. Immunol Lett 2003;86:121.
4. Kis B, Snipes JA, Busija DW. Paracetamol and the Cyclooxygenase-3 puzzle: sorting out facts, fictions and uncertainties. J Pharmacol Exp Ther 2005;315:1-7.
5. Hinz B, Cheremina O, Brune K. Paracetamol (acetaminophen) is a selective cyclooxygenase-2 inhibitor in man. FASEB J 2008;22:383-90.
6. Lee Y-S, Kim H, Brahim JS, Rowan J, Lee G, Dionne RA. Paracetamol selectively suppresses peripheral prostaglandin E2 release and increases COX-2 gene expression in a clinical model of acute inflammation. Pain 2007;129:279-86.
7. Rezende RM, França DS, Menezes GB, dos Reis WGP, Bakhle YS, Francischi JN. Different mechanisms underlie the analgesic actions of paracetamol and dipyrone in a rat model of inflammatory pain. Br J Pharmacol 2007;153:760-8.
8. Graham GG, Scott KF. Mechanism of action of paracetamol. Am J Ther 2005;12:46-55.
9. Bertolini A, Ferrari A, Ottani A, Guerzoni S, Tacchi R, Leone S. Paracetamol: new vistas of an old drug. CNS Drug Rev 2006;12:250-75.
10. Ottani A, Leone S, Sandrini M, Ferrari A, Bertolini A. The analgesic activity of paracetamol is prevented by the blockade of cannabinoid CB1 receptors. Eur J Pharmacol 2006;531:280-1.
11. Mallet C, Daulhac L, Bonnefont J, Ledent C, Etienne M, Chapuy E, et al. Endocannabinoid and serotonergic systems are needed for paracetamol-induced analgesia. Pain 2008;139:190-200.
12. Andersson DA, Gentry C, Alenmyr L, Killander D, Lewis SE, Andersson A et al. TRPA1 mediates spinal antinociception induced by acetaminophen and the cannabinoid Δ(9)-tetrahydrocannabiorcol. Nat Commun 2011;2:551.
13. Pelissier T, Alloui A, Caussade F, Dubray C, Cloarec A, Lavarenne J et al. Paracetamol exerts a spinal antinociceptive effect involving an indirect interaction with 5-hydroxytryptamine3-receptors: in vivo and in vitro evidence. J Pharmacol Exp Ther 1996;278:8-14.
14. Alloui A, Pelissier T, Dubray C, Lavarenne J, Eschalier A. Tropisetron inhibits the antinociceptive effect of intrathecally administered paracetamol and serotonin. Fundam Clin Pharmacol 1996;10:406-7.
15. Libert F, Bonnefont J, Bourinet E, Doucet E, Alloui A, Hamon M et al. Paracetamol: a central analgesic drug that involves a spinal tropisetron-sensitive, non-5-HT3 receptor-mediated effect. Mol Pharmacol 2004;66:728-34.
16. Girard P, Pansart Y, Coppé M-C, Niedergang B, Gillardin J-M. Modulation of paracetamol and nefopam antinociception by serotonin 5-HT3 receptor antagonists in mice. Pharmacology 2009;83:243-6.
17. Minville V, Fourcade O, Mazoit JX, Girolami JP, Tack I. Ondansetron does not block paracetamol-induced analgesia in a mouse model of fracture pain. Br J Anaesth 2011;106:112-8.
18. Pickering G, Loriot MA, Libert F, Eschalier A, Beaune P, Dubray C. Analgesic effect of paracetamol in humans: first evidence of a central serotonergic mechanism. Clin Pharmacol Ther 2006;79:371-8.
19. Pickering G, Estève V, Loriot MA, Eschalier A, Dubray C. Paracetamol reinforces descending inhibitory pain pathways. Clin Pharmacol Ther 2008;84:47-51.
20. Jokela R, Ahonen J, Seitsonen E, Marjakangas P, Korttila K. The influence of ondansetron on the analgesic effect of paracetamol after laparoscopic hysterectomy. Clin Pharmacol Ther 2010;87:672-8.
21. Pickering G, Faure M, Commun F, Carrier deBoissyE, Roche G, Mom T et al. Tropisetron and paracetamol association in post-operative patients. Fundam Clin Pharmacol 2012;26:432-7.
22. Hamunen K, Kontinen V, Hakala E, Talke P, Paloheimo M, Kalso E. Effect of pain on autonomic nervous system indices derived from photoplethysmography in healthy volunteers. Br J Anesth 2012; Feb 26:1-7.
23. Noseir RK, Ficke DJ, Kundu A, Arain SR, Ebert TJ. Sympathetic and vascular consequences from remifentanil in humans. Anesth Analg 2003;96:1645-50.
24. Lundeberg T, Lund I, Dahlin L, Borg E, Gustafsson C, Sandin L et al. Reliability and responsiveness of three different pain assessments. J Rehabil Med 2001;33:279-83.
25. Stener-Victorin E, Kowalski J, Lundeberg T. A new highly reliable instrument for the assessment of pre- and postoperative gynecological pain. Anesth Analg 2002;95:151-7.
26. Nielsen PR, Nørgaard L, Rasmussen LS, Kehlet H. Prediction of post-operative pain by an electrical pain stimulus. Acta Anaesthesiol Scand 2007;51:582-6.
27. Ye JH, Mui WC, Ren J, Hunt TE, Wu WH, Zbuzek VK. Ondansetron exhibits the properties of a local anesthetic. Anesth Analg 1997;85:1116-21.
28. Färber L, Stratz T, Brückle W, Späth M, Pongratz D, Lautenschläger J et al. Efficacy and tolerability of tropisetron in primary fibromyalgia - a highly selective and competitive 5-HT3 receptor antagonist. German Fibromyalgia Study Group. Scand J Rheumatol Suppl 2000;113:49-54.
29. Stratz T, Müller W. Treatment of chronic low back pain with tropisetron. Scand J Rheumatol, Suppl 2004;119:76-78.
30. Samborski W, Stratz T, Mackiewitz S, Müller W. Intra-articular treatment of arthritides and activated osteoarthritis with the 5-HT3 receptor antagonist. A double-blind study compared with methylprednisolone. Scand J Rheumatol, Suppl 2004;119:51-54.
31. Staahl C, Olesen A, Andresen T, Arendt-Nielsen L, Drewes A. Assessing efficacy of non-opioid analgesics in experimental pain models in healthy volunteers: an updated review. Br J Clin Pharmacol 2009;68:322-41.
32. Olesen AE, Andresen T, Staahl C, Drewes AM. Human experimental pain models for assessing the therapeutic efficacy of analgesic drugs. Pharmacol Rev 2012;64:722-79.
33. Bromm B, Forth W, Richter E, Scharein E. Effects of paracetamol and antipyrine on non-inflammatory pain and EEG activity. Pain 1992;50:213-21.
34. Yuan C-S, Karrison T, Wu JA, Lowell T, Lynch J, Foss J. Dose-related effects of oral paracetamol on cold-induced pain: A double-blind, randomized, placebo-controlled trial. Clin Pharmacol Ther 1998;63:379-83.
35. Miner J. Randomized double-blind placebo controlled crossover study of paracetamol, ibuprofen, paracetamol/hydrocodone, and placebo for the relief of pain from a standard painful stimulus. Acad Emerg Med 2009;16:911-4.
36. Munsterhjelm E, Munsterhjelm N, Niemi T, Ylikorkala O, Neuvonen P, Rosenberg P. Dose-dependent inhibition of platelet function by paracetamol in healthy volunteers. Anesthesiology 2005;103:712-7.
37. Nielsen JC, Bjerring P, Arendt-Nielsen L. A comparison of the hypoalgesic effect of paracetamol in slow-release and plain tablets on laser-induced pain. Br J Clin Pharmacol 1991;31:267-70.
38. Nielsen JC, Bjerring P, Arendt-Nielsen L, Petterson KJ. Analgesic efficacy of immediate and sustained release paracetamol and plasma concentration of paracetamol. Double blind, placebo-controlled evaluation using painful laser stimulation. Eur J Clin Pharmacol 1992;42:261-4.
39. Olesen AE, Staahl C, Ali Z, Drewes AM, Arendt-Nielsen L. Effects of paracetamol combined with dextromethorphan in human experimental muscle and skin pain. Basic Clin Pharmacol Toxicol 2007;101:172-6.
40. Romundstad L, Stubhaug A, Niemi G, Rosseland LA, Breivik H. Adding propacetamol to ketorolac increases the tolerance to painful pressure. Eur J Pain 2006;10:177-83.
41. Renner B, Clarke G, Grattan T, Beisel A, Mueller C, Werner U et al. Caffeine accelerates absorption and enhances the analgesic effect of paracetamol. J Clin Pharmacol 2007;47:715-26.
42. Koppert W, Wehrfritz A, Korber N, Sittl R, Albrecht S, Schuttler J et al. The cyclooxygenase isozyme inhibitors parecoxib and paracetamol reduce central hyperalgesia in humans. Pain 2004;108:148-53.
43. Filitz J, Ihmsen H, Gunther W, Troster A, Schwilden H, Schuttler J et al. Supra-additive effects of tramadol and paracetamol in a human pain model. Pain 2008;136:262-70.
44. Dusch M, Namer B, Strupf M, Schley M, Rukwied R, Hägglöf B et al. Cross-over evaluation of electrically induced pain and hyperalgesia. Scand J Pain 2010;1:205-10.
45. Chassaing C, Schmidt J, Eschalier A, Cardot JM, Dubray C. Hyperalgesia induced by cutaneous freeze injury for testing analgesics in healthy volunteers. Br J Clin Pharmacol 2006;61:389-97.
46. Bandschapp O, Filitz J, Urwyler A, Koppert W, Ruppen W. Tropisetron blocks analgesic action of paracetamol: a human pain model study. Pain 2011;152:1304-10.